Francois Nader - 13 Jun 2023 Form 4 Insider Report for Talaris Therapeutics, Inc. (TALS)

Role
Director
Signature
/s/ Mary Kay Fenton, attorney-in-fact
Issuer symbol
TALS
Transactions as of
13 Jun 2023
Net transactions value
$0
Form type
4
Filing time
14 Jun 2023, 19:00:36 UTC
Previous filing
05 May 2023
Next filing
07 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TALS Stock Option (Right to Buy) Award $0 +41,000 $0.000000 41,000 13 Jun 2023 Common Stock 41,000 $2.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest as follows: the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting.